vcfirmsdirectory.com

Venture capital

ARCH Venture Partners

ARCH Venture Partners is a science-driven venture firm based in Chicago and Seattle that founds and funds companies built on new technologies, with a portfolio concentrated in biotechnology and therapeutics.

Chicago · SeattleRegistered · Chicago
New investments · 12 months
Fund vehiclesPublic
13
13 active · US private fund
First chequePublic
From $50K
From the firm’s website
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: archventure.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round ARCH Venture Partners joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is ARCH Venture Partners right for your round?

Is ARCH Venture Partners a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
13
13 active · US private fund
SEC adviser filings
First chequePublic
From $50K
From the firm’s website
archventure.com
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

ARCH VENTURE FUND XIII, LPUS private fund · Active · United States · $3.3B gross assets · filed 30 Mar 2026
ARCH VENTURE FUND XII, LPUS private fund · Active · United States · $3B gross assets · filed 30 Mar 2026
ARCH VENTURE FUND XI, LPUS private fund · Active · United States · $1.6B gross assets · filed 30 Mar 2026
ARCH VENTURE FUND X OVERAGE LPUS private fund · Active · United States · $530.4M gross assets · filed 30 Mar 2026
ARCH VENTURE FUND X LPUS private fund · Active · United States · $493.4M gross assets · filed 30 Mar 2026
ARCH VENTURE FUND IX LPUS private fund · Active · United States · $486.3M gross assets · filed 30 Mar 2026
ARCH VENTURE FUND IX OVERAGE LPUS private fund · Active · United States · $438.8M gross assets · filed 30 Mar 2026
ARCH VENTURE FUND VIII LPUS private fund · Active · United States · $384.3M gross assets · filed 30 Mar 2026
ARCH VENTURE FUND VIII OVERAGE LPUS private fund · Active · United States · $156M gross assets · filed 30 Mar 2026
ARCH VENTURE FUND VII LPUS private fund · Active · United States · $108M gross assets · filed 30 Mar 2026
ARCH VENTURE FUND V LPUS private fund · Active · United States · $31.7M gross assets · filed 30 Mar 2026
HEALTHCARE FOCUS FUND LPUS private fund · Active · United States · $5.1M gross assets · filed 30 Mar 2026
1 more fund vehicleSEC adviser filings
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds ARCH Venture Partners joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

9 rounds in the last 12 months

Round sizes, ARCH Venture Partners’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

908 DevicesAccompany HealthAera TherapeuticsAgios PharmaceuticalsAIRNAAkamis BioAledadeAlnylam PharmaceuticalsAltos LabsArbor Biotechnologiesand 118 more

Portfolio and exits

Every company ARCH Venture Partners backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where ARCH Venture Partners puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet ARCH Venture Partners

Events where ARCH Venture Partners’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet ARCH Venture Partners’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

22 Sep 2026New deal
9 Sep 2026New deal
8 Sep 2026New deal
7 Jul 2026New deal
25 Jun 2026New deal
30 Mar 2026Fund filingForm ADV filed by ARCH VENTURE PARTNERS: 13 private funds, $10.5B in gross assets.SEC Form ADV · public record
12 Jan 2026New deal
8 Jan 2026New deal

Founders also look at

Frequently asked questions

ARCH Venture Partners is based in Chicago, United States. It also has an office in Seattle.

13 fund vehicles are on public registers (SEC adviser filings), including ARCH VENTURE FUND XIII, LP, ARCH VENTURE FUND XII, LP and ARCH VENTURE FUND XI, LP.

ARCH follows the science to create companies around revolutionary technologies, taking a contrarian, long-term view. It sizes its investments to each company's needs, from very small initial checks to very large rounds. It also draws on a wide partner network to help companies through formation and growth. From the firm’s own website.

From $50K per investment, according to the firm’s own website.

ARCH Venture Partners lists 128 portfolio companies on its website, including 908 Devices, Accompany Health, Aera Therapeutics, Agios Pharmaceuticals and AIRNA.

Firms whose websites list some of the same companies include Foresite Capital, Pivotal Life Sciences and RA Capital.

Know before ARCH Venture Partners’s next round is announced.

PRO tracks ARCH Venture Partners’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

ARCH Venture PartnersGet ARCH Venture Partners’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.